Search research articles
Contact Us
Filters
Showing results (401-410 of 424) with videos related to
Page
of 43
Sort By:
Cell Death & Disease
|
January 26, 2018
miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
Wei Kang, Tingting Huang, Yuhang Zhou, et al.
Journal of Crohn'S & Colitis
|
January 24, 2016
Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10
Alfa H C Bai, William K K Wu, Liangliang Xu, et al.
Clinical Chemistry
|
June 16, 2018
Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers with or without Liver Metastases
Wanxia Gai, Lu Ji, W K Jacky Lam, et al.
Gut
|
September 24, 2017
Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
Jingying Zhou, Man Liu, Hanyong Sun, et al.
Blood
|
December 19, 2015
Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors
Brian M Dulmovits, Abena O Appiah-Kubi, Julien Papoin, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
June 6, 2022
Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy
S S K Ho, S S F Hon, E Hung, et al.
Environmental Science & Technology Letters
|
February 25, 2026
The risks to human health of air toxics, PM<sub>2.5</sub>, and ozone from the 2023 Canadian wildfires
Havala O T Pye, William T Hutzell, Neal L Fann, et al.
Gut
|
May 12, 2019
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
Man Liu, Jingying Zhou, Xiaoyu Liu, et al.
Cancer Research
|
July 14, 2025
FADD Activation in Hepatocellular Carcinoma Potentiates CD8+T Cell Responses and Sensitizes to Immune Checkpoint Inhibitors
Jiahuan Lu, Thomas Ting-Hei Chan, Yun Wang, et al.
The British Journal of Surgery
|
October 13, 2021
Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study
J-H Zhong, B-C Xing, W-G Zhang, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 424) with videos related to
Sort By:
Page
of 43
Cell Death & Disease
|
January 26, 2018
miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
Wei Kang, Tingting Huang, Yuhang Zhou, et al.
Journal of Crohn'S & Colitis
|
January 24, 2016
Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10
Alfa H C Bai, William K K Wu, Liangliang Xu, et al.
Clinical Chemistry
|
June 16, 2018
Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers with or without Liver Metastases
Wanxia Gai, Lu Ji, W K Jacky Lam, et al.
Gut
|
September 24, 2017
Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
Jingying Zhou, Man Liu, Hanyong Sun, et al.
Blood
|
December 19, 2015
Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors
Brian M Dulmovits, Abena O Appiah-Kubi, Julien Papoin, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
June 6, 2022
Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy
S S K Ho, S S F Hon, E Hung, et al.
Environmental Science & Technology Letters
|
February 25, 2026
The risks to human health of air toxics, PM<sub>2.5</sub>, and ozone from the 2023 Canadian wildfires
Havala O T Pye, William T Hutzell, Neal L Fann, et al.
Gut
|
May 12, 2019
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
Man Liu, Jingying Zhou, Xiaoyu Liu, et al.
Cancer Research
|
July 14, 2025
FADD Activation in Hepatocellular Carcinoma Potentiates CD8+T Cell Responses and Sensitizes to Immune Checkpoint Inhibitors
Jiahuan Lu, Thomas Ting-Hei Chan, Yun Wang, et al.
The British Journal of Surgery
|
October 13, 2021
Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study
J-H Zhong, B-C Xing, W-G Zhang, et al.
Page
of 43